Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience - Dima, Danai; Davis, James A.; Ahmed, Nausheen; Jia, Xuefei; Sannareddy, Aishwarya; Shaikh, Hira; Shune, Leyla; Kaur, Gurbakhash; Khouri, Jack; Afrough, Aimaz; Strouse, Christopher; Lochner, Jonathan; et al. (Transplantation and cellular therapy, 2024)
Keywords: Aged; Antibodies, Bispecific; Antineoplastic Agents - adverse effects; B-Cell Maturation Antigen; BCMA; Bispecific; Humans; Multiple myeloma; Multiple Myeloma - drug therapy; Neoplasms, Plasma Cell; Refractory; Relapsed; Retrospective Studies; T cell engager; Refractory; BCMA; Bispecific; Relapsed; Multiple myeloma; T cell engager